Member Companies of the Opioid PMR Consortium Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2016
NCT02741076
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

morphine (1 trial)

oxycodone (oxycontin) (1 trial)

oxymorphone (opana) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chronic Pain (Phase 4)

Opioid-Related Disorders (Phase 4)

Substance-Related Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3